Upcoming APAC event! This Saturday, Oct 17, we'll be in Adelaide for the USANZ South Australia and Northern Territory Section Meeting. Join us to learn how Cxbladder genomic tests are helping clinical teams risk stratify haematuria patients and those being monitored for recurrent NMIBC. #NonInvasive #UCRuleOut

A thought-provoking conversation with AUA President and Kaiser Permanente Chair of Urology Dr Eugene Rhee on the future of urology and the role of the AUA in advancing innovation, education and collaboration across the specialty. As new diagnostic technologies and precision medicine approaches continue to emerge, evidence-based guidance is critical to informed clinical decision-making and improved patient outcomes. We appreciate the AUA's leadership across urology to help ensure innovation translates to meaningful benefits for patients.

Upcoming event! From Sunday, we'll be at the Annual Meeting of the American Urogynecologic Society (AUGS). Tying in to this year's theme - Innovations and Practice-Changing Science, and a meeting focus on forward-thinking research and clinical excellence, we're looking forward to discussing Triage Plus, our next generation Cxbladder genomic test for the risk stratification of patients presenting with microhematuria. To learn more, we invite you to join us at the Cxbladder booth. With the publication of LCD DL40378, Triage Plus is expected to be covered by Medicare in appropriately counseled intermediate risk patients.  #NonInvasive #UCRiskStratification

Expert Webinar - Cxbladder Triage Plus for Microhematuria Evaluation: hubs.la/Q04y0KJv0 Pacific Edge Chief Medical Officer Dr Tamer Aboushwareb provides an overview, discussing:  - Nuances in hematuria evaluation and the impact of recent AUA/SUFU Microhematuria Guideline changes - The advantages of urine-based genomic testing supported with real world evidence  - The development and clinical validation of Triage Plus, including active studies - Practical considerations in the use of Triage Plus  Watch the video: hubs.la/Q04y0KJv0 US clinicians: With the publication of LCD DL40378, Triage Plus is expected to be covered by Medicare for the evaluation of appropriately counseled intermediate risk microhematuria patients.

A note for Australian clinical teams: From Monday we'll be exhibiting at the Australian National Rural Health Conference in Adelaide. If you're attending, we invite you to join us and learn more about our suite of Cxbladder non-invasive genomic tests, including Triage Plus, a next generation Cxbladder test for haematuria evaluation, and Cxbladder Monitor for NMIBC surveillance. #UCRiskStratification

Cxbladder Triage Plus, with added DNA markers, enhances microhematuria risk stratification via significant improvements in NPV, Sensitivity, PPV and Specificity over our established Cxbladder Triage and Detect tests. With the publication of LCD DL40378 in May, we expect that Cxbladder Triage Plus will be covered by Medicare in the United States for the risk stratification of appropriately counselled intermediate risk microhematuria patients. Learn more at hubs.la/Q04x5kt30

Upcoming event! This week we'll be in Roanoke, Virginia for the Annual Meeting of the Mid-Atlantic Section of the AUA. If you're planning to attend, make sure you stop by and visit us at the Cxbladder booth. We'd love the opportunity to discuss Triage Plus, our next generation Cxbladder test expected to be covered by Medicare for the evaluation of intermediate risk microhematuria patients.  #NonInvasive #UCRiskStratification #MAAUA26

Lots of interest in Cxbladder and non-invasive genomic testing at #UAA2026 in Manila today. If you're attending and haven't already, make sure you come and visit us at booth 140. #HematuriaEvaluation #NMIBCSurveillance #UCRiskStratification

An update for clinicians around the Asia Pacific region! The Urological Association of Asia (UAA) Congress 2026 begins in Manila on 3 September. If you’re planning to attend, we invite you to join us at Booth #140. Two discussion topics we’ll be leading at the event – the use of Cxbladder Triage Plus for hematuria evaluation and the use of Cxbladder Monitor for NMIBC surveillance. Learn more: hubs.la/Q04vjJDM0 #UAA2026

Enhanced Microhematuria Risk Stratification - Prioritize Those Who Require Urgent Care. Triage Plus delivers significant improvement in NPV, Sensitivity, PPV and Specificity over our established Cxbladder Triage and Detect tests, empowering clinical teams to optimize practice workflow and focus clinical resources on high risk patients and procedures. Learn more and review the DRIVE study which provides clinical validation: hubs.la/Q04tM8_20. Triage Plus builds on the performance of Cxbladder Triage, a test now included in the AUA/SUFU Microhematuria Guideline. == US Clinicians: With the publication of LCD DL4030378 in May, we expect that Cxbladder Triage Plus will be covered by Medicare for the risk stratification of appropriately consulted intermediate risk microhematuria patients.

An important message for US clinicians: Cxbladder Triage Plus is a next generation Cxbladder test that employs a novel combination of mRNA and DNA biomarkers to enhance microhematuria risk stratification, delivering significant performance improvements over our established Triage and Detect tests. With LCD DL4030378 proposing Medicare coverage for Triage Plus in the risk stratification of appropriately consulted intermediate risk patients, we’re now pleased to offer the test to all our US customers. Learn more: hubs.la/Q04rrxR-0

British comedian Alan Davies kicks off his New Zealand tour today and we'd like to thank his team and participating venues throughout New Zealand for letting us promote an important symptoms awareness message as guests take a break during the show. As we like to say, some things should be red, not your pee. If you see red, speak to your GP. If you haven't already, make sure you read Alan's article in Stuff Magazine: hubs.ly/Q04rrwgp0. We also encourage you to support Alan on tour: hubs.ly/Q04rrsjD0 A big thank you to all the venues that have pledged their support thus far: BNZ Theatre Hamilton, Addison Theatre Tauranga, Napier Municipal Theatre, Michael Fowler Centre Wellington, and the Regent Theatre Dunedin.

A reminder why it's so important to recognise the symptoms: hubs.la/Q04mp1zK0 Blood in urine is the most common symptom of bladder cancer and often the first sign. If you see red in your pee, speak to your GP. The disease is highly treatable when caught early. We're fans and wish Alan well. See you in Dunedin on the 13th August!

#WatchNow. Late last year we hosted an expert panel discussion focused on the utility of Cxbladder Triage in the evaluation of patients with microhematuria. In this mini-clip, taken from the 50min session, Dr. Jhaveri and Dr. Goldfischer discuss the use of Cxbladder to help optimize practice workflow, prioritizing those who require care: hubs.la/Q04lMVzh0 View the full webinar: hubs.la/Q04lMxhH0 == Cxbladder Triage is a non-invasive genomic urine test optimized to risk stratify and rule out urothelial cancer in patients presenting with microhematuria. The test is included in the AUA/ SUFU Microhematuria Guideline, supported with Grade A evidence, and US Medicare coverage for the use of Triage and Triage Plus in appropriately counseled intermediate risk patients has been proposed with the recent publication of a draft LCD. Learn more: hubs.la/Q04lMbND0

In keeping with tradition, the team wrap up Bladder Cancer Awareness Month 2026 with creativity and style. The reveal is always a lot of fun. Needless to say it was a colourful morning! #BCAM26 #BladderCancerMonth26 #BladderCancerAwarenessMonth

While men are more likely to develop bladder cancer, it's often detected later in women when the disease has advanced, leading to a poorer prognosis and worse outcomes*. Be #BladderCancerAware this May. Learn more via @BladderCancerUS: Bladder Cancer in Women - Signs, Symptoms, and Treatments: hubs.ly/Q04hQKJf0 #BCAM26 #BladderCancerMonth26 #BladderCancerAwarenessMonth == *Leslie et al. Bladder Cancer. Last updated 2024. Stat Pearls

It was our pleasure to take part in BEAT Bladder Cancer's Anna's Walk in Wellington over the weekend. It's a cause that's personal to so many of us and it was inspiring to see such support from the community. Credit to Rose, Mark, Justine, Michelle, and Team for all their hard work making the event so special. #BCAM26 #BladderCancerMonth26 #BladderCancerAwarenessMonth

Smoking is the leading preventable cause of bladder cancer. If you smoke, your risk of getting bladder cancer is 3 times that of someone who has never smoked*. Be #BladderCancerAware this May. Learn more about bladder cancer causes and risk factors: hubs.la/Q04h31450 #BCAM26 #BladderCancerMonth26 #BladderCancerAwarenessMonth ==== *Cancer Research UK, American Cancer Society 2026

Greetings from Washington DC! It's great to see so many of you at #AUA2026. The hot topic today... this week's draft LCD which establishes hematuria evaluation as a covered Medicare benefit for the first time, and includes explicit coding guidance for both Cxbladder Triage and Triage Plus. It's a great outcome for Medicare patients, urologists, and the broader healthcare system, and we invite you to join us at booth #3707. We'ready to answer all your questions. Learn more about the proposed LCD: hubs.la/Q04gS7R20